Posted on 10/17/18
Neon Therapeutics Is An Emerging Player In Personalized Immunotherapy With Catalysts Ahead
SummaryNeon Therapeutics is a clinical-stage biotechnology company focused on leveraging neoantigen technology to provide patients with personalized immunotherapies for cancer treatment.Neon has come down substantially since . . .
Posted on 8/23/18
bluebird bio: Heading To $200 On Pipeline Progress And Potential M&A
Summarybluebird bio is a clinical-stage biotechnology company focused on gene therapy, cancer immunopathy and gene editing for the treatment of cancer and rare diseases.Its gene therapy . . .
Posted on 7/18/18
Fortress Biotech: Highly Complex, Greatly Undervalued
SummaryFortress Biotech is a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology products.Company assets include interests in ten biotech companies, three of . . .
Posted on 7/9/18
Paratek Pharmaceuticals: Three PDUFA Dates, One Option Trade
Editor's note: Seeking Alpha is proud to welcome JV Biotech as a new contributor. It's easy to become a Seeking Alpha contributor and earn money for . . .

